The role of conductive nanoparticles in anaerobic digestion: Mechanism, current status and future perspectives

Chemosphere ◽  
2021 ◽  
Vol 280 ◽  
pp. 130601
Author(s):  
Smita S. Kumar ◽  
Pooja Ghosh ◽  
Navish Kataria ◽  
Deepak Kumar ◽  
Sveta Thakur ◽  
...  
2018 ◽  
Vol 23 (37) ◽  
pp. 5760-5765 ◽  
Author(s):  
Antonio Gambardella ◽  
Angelo Labate ◽  
Laura Mumoli ◽  
Iscia Lopes-Cendes ◽  
Fernando Cendes

Author(s):  
Radhakrishnan Narayanaswamy ◽  
Intan Safinar Ismail

Vitiligo is a depigmentation disorder with complex causes. Nonetheless, recent progress has been made to unravel the pathophysiology of vitiligo. In this review, we provide an overview of the currently known herbal medicine for vitiligo treatment and also highlighted the herbs that have been used in clinical trials. In view of traditional uses, herbs such as Ammi visnaga L., Angelica sinensis, Eclipta alba L, Ginkgo biloba, Picrorhiza kurroa Royle Ex Benth, and Psoralea corylifolia L, have been highlighted. Enormous efforts in vitiligo drug discovery are currently needed. Interleukin-17 inhibition, tumor necrosis factor-alpha inhibition, heat shock protein-70i (HSP70i) inhibition, keratinocyte turnover modulators, and regulatory T cells (Tregs) modulators have been discussed as promising new targets for vitiligo drug development. Thus, we strongly believe that this review may be useful for rationalize new herbal drug for vitiligo treatment.


2019 ◽  
Vol 58 (3) ◽  
pp. 353-362 ◽  
Author(s):  
Zulfikar Azam ◽  
Véronique Quillien ◽  
Gang Wang ◽  
Shing-Shun Tony To

2014 ◽  
Vol 83 (3) ◽  
pp. 450-455 ◽  
Author(s):  
Fabio Piscaglia ◽  
Sara Marinelli ◽  
Simona Bota ◽  
Carla Serra ◽  
Laura Venerandi ◽  
...  

2011 ◽  
Vol 43 (3) ◽  
pp. 228-253 ◽  
Author(s):  
Anne Matthys ◽  
Guy Haegeman ◽  
Kathleen Van Craenenbroeck ◽  
Peter Vanhoenacker

2020 ◽  
Vol 13 (1) ◽  
Author(s):  
Zengli Fang ◽  
Jin Xu ◽  
Bo Zhang ◽  
Wei Wang ◽  
Jiang Liu ◽  
...  

AbstractAs the most important component of the stromal cell population in the tumor microenvironment (TME), cancer-associated fibroblasts (CAFs) are crucial players in tumor initiation and progression. The interaction between CAFs and tumor cells, as well as the resulting effect, is much greater than initially expected. Numerous studies have shown that noncoding RNAs (ncRNAs) play an irreplaceable role in this interplay, and related evidence continues to emerge and advance. Under the action of ncRNAs, normal fibroblasts are directly or indirectly activated into CAFs, and their metabolic characteristics are changed; thus, CAFs can more effectively promote tumor progression. Moreover, via ncRNAs, activated CAFs can affect the gene expression and secretory characteristics of cells, alter the TME and enhance malignant biological processes in tumor cells to contribute to tumor promotion. Previously, ncRNA dysregulation was considered the main mechanism by which ncRNAs participate in the crosstalk between CAFs and tumor cells. Recently, however, exosomes containing ncRNAs have been identified as another vital mode of interaction between these two types of cells, with a more direct and clear function. Gaining an in-depth understanding of ncRNAs in CAFs and the complex regulatory network connecting CAFs with tumor cells might help us to establish more effective and safer approaches for cancer therapies targeting ncRNAs and CAFs and offer new hope for cancer patients.


2021 ◽  
Vol 17 (11) ◽  
pp. 2737-2755
Author(s):  
Yifan Li ◽  
Lan Lu ◽  
Xu Wu ◽  
Qianxiu Li ◽  
Yueshui Zhao ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document